Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway

Fig. 1

High expression of NSD1 in HCC was associated with poor prognosis. a, Expression of NSD1 in normal tissue and primary HCC tumor tissue analyzed by microarray-based analysis (http://ualcan.path.uab.edu/index.html). b, Relative expression of NSD1 in adjacent normal and HCC tissues (n = 63) determined by RT-qPCR. c, Kaplan-Meier survival curve for analysis on the relation between NSD1 expression and prognosis in patients with HCC. * p < 0.05 vs. adjacent normal tissues. Data (mean ± s.d.) between two groups were examined by paired t test

Back to article page